Body20 vs AKT

Body20 is the stronger opportunity right now, and the advantage is overwhelmingly about timing and terrain. Their FDD is current (2025 fiscal, filing status DUE), which means you can walk into a sales conversation with accurate unit counts, real AUVs, and a royalty structure you can model against. AKT’s filing is overdue—you’re selling blind into stale data, and that kills credibility with franchisees who scrutinize every line item before buying software. The 35.6% unit growth at Body20 also gives you a moving target that’s actively adding locations, each one a fresh implementation and training cycle.

The budget dimension seals it. Body20’s $469K AUV against an 8% royalty and 4% ad fund means franchisees are operating on tight unit-level margins, which makes labor-shedding automation (scheduling, back-office) a painkiller purchase, not a vitamin. The franchisor-controlled procurement model is the real terrain unlock: you only need to win one corporate-level deal to get pushed down to 61 franchised units, rather than fighting location by location. AKT’s missing data hides whether they even have that centralized buying lever.

The tradeoff is TAM. Body20’s 62 total units cap your initial addressable market, and a single-brand bet here means you’re fishing in a small pond. But a small pond with a fresh FDD, rapid growth, and a single throat to choke in procurement beats a potentially larger brand where you can’t even verify the basics.

Verdict: Sell into Body20 now—the filing is fresh, the procurement is centralized, and the growth curve gives you a recurring implementation pipeline that AKT can’t match until they fix their compliance.